Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Olema Pharmaceuticals, Inc. (OLMA) had Return on Equity of -12.68% for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
-- |
|
$-43.78M |
|
-- |
|
-- |
|
$47.86M |
|
$-47.86M |
|
$4.08M |
|
$-43.78M |
|
$-43.78M |
|
$-43.78M |
|
$-43.78M |
|
$-43.78M |
|
$-43.78M |
|
$-47.86M |
|
$-47.73M |
|
85.50M |
|
85.50M |
|
$-0.51 |
|
$-0.51 |
|
Balance Sheet Financials | |
$367.73M |
|
-- |
|
$14.28M |
|
$382.00M |
|
$33.16M |
|
$3.00M |
|
$3.60M |
|
$36.77M |
|
$345.24M |
|
$345.24M |
|
$345.24M |
|
68.63M |
|
Cash Flow Statement Financials | |
$-73.86M |
|
$-10.85M |
|
$-2.30M |
|
$139.48M |
|
$52.47M |
|
$-87.01M |
|
$9.07M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
11.09 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-73.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
Return on Equity |
-12.68% |
-12.68% |
|
-11.46% |
|
-12.57% |
|
$5.03 |
|
$-0.86 |
|
$-0.86 |